Orexo US, Inc. Email Format

Biotechnology ResearchNew Jersey, United States11-50 Employees

Orexo US, Inc. serves as the United States operating arm of Orexo AB, a pharmaceutical company focused on advancing treatments for severe diseases and on life-saving rescue medications. Based in Morristown, New Jersey, the organization operates within the biotechnology research sector and maintains a relatively small team. Its core technology, AmorphOX, is a proprietary drug-delivery platform that improves bioavailability and stability for both large and small molecules, enabling new possibilities in administration, manufacturing, and distribution. The organization operates in the pharmaceutical space, focusing on drug-delivery solutions that address healthcare needs. Recent activity includes presenting clinical data for OX640 at the EAACI Congress in 2025, illustrating ongoing development work. In 2024, Orexo announced collaborations to develop nasal powder vaccines using AmorphOX technology, signaling expansion into mucosal vaccine platforms.

Sign up for free to view info

Company overview Employee directory